| Article
A retrospective study published in Cureus evaluated greater occipital nerve (GON) blocks in severe medically refractory headaches in those 18 years of age or younger. The blocks consisted of chirocaine and depomedrone in 1, 2, or 3 administrations. Although the test group consisted of only 6...
| Article
Nerve compression headaches. Will surgery help those undergoing trigger-site deactivation? The journal of Plastic and Reconstructive Surgery reports a novel way to evaluate a patient’s potential response to surgery: pain drawings as interpreted by artificial intelligence. Asking patients to draw...
| Article
| Article
Chronic migraine is disabling, complex, and an expensive global burden; it has also been studied far less than episodic migraine. A review in BMJ focused on treatments, including calcitonin gene related peptide antagonists and neuromodulatory devices. Via keywords searches, including “chronic...
| Article
A qualitative study in the Headache journal asked children and their caregivers about treatment preferences regarding migraine. Although soliciting opinions from those involved in treatments is valuable, too little research has been done to find out what matters most. Via stratified purposive...
| Article
Headache disorders “are among the most prevalent and disabling conditions worldwide,” according to the Global Burden of Disease (GBD) study. A review in The Journal of Headache and Pain identified over 350 relevant published papers. Among the findings are the percent of the population with:
- Activ...
| Video
How do hormones affect migraine? We asked PAINWeek faculty member Dr. Nick Knezevic, clinical professor of Anesthesiology and Surgery at the University of Illinois in Chicago.
| Article
The Journal of Clinical Medicine has published an article: Trends in the Management of Headache Disorders in US Emergency Departments: Analysis of 2007–2018 National Hospital Ambulatory Medical Care Survey Data. Researchers identified headache disorders—including migraine, tension-type headache...
| Video
What are cervicogenic headaches? How do they differ from migraine and other headache presentations? Dr. Nick Knezevic, clinical professor of Anesthesiology and Surgery at the University of Illinois in Chicago explains
| Article
JAMA Neurology reports findings gathered from over 2600 migraine sufferers, aged 18 to 65, from 4 randomized clinical trials. Researchers sought to determine whether erenumab would improve migraine frequency and lessen migraine medication need in those with and without aura. The study notes, “One or...
Pagination
- Page 1
- Next page